House Bill No. by Representative Bagley enacts R.S. 22:1077.3, which mandates health insurance coverage for a patient's choice of medical and surgical treatments following a cancer diagnosis. The bill emphasizes that treatment decisions should be made solely by the patient in consultation with their attending physicians, ensuring that all medically necessary treatments are covered. It also requires that consulting physicians adhere to recognized, evidence-based standards, such as those from the National Comprehensive Cancer Network, when making treatment recommendations.

Additionally, the bill stipulates that health benefit plans providing cancer treatment must cover procedures addressing urinary and sexual dysfunction resulting from cancer treatments, including options like penile injections and surgical implants. The definitions of "health benefit plan" and "health insurance issuer" are clarified to encompass various types of insurance policies and entities involved in healthcare services. This legislation will apply to new policies issued on or after January 1, 2025, with existing policies required to conform by their renewal date, but no later than January 1, 2026.